Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

Ana Oaknin, Kathleen N. Moore, Tim Meyer, José López-Picazo González, Lot A. Devriese, Asim Amin, Christopher D. Lao, Valentina Boni, William H. Sharfman, Jong Chul Park,

The Lancet Oncology · 2024 · 59 citations · 19 references

DOIFull text

Open access

Concepts

References

19